—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Virbac SA (VIRP.PA) — the peer cohort

As of 2026-10-12 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Virbac SA ranks 11 of 13 in its cohort on the Closelooknet composite (47/100) — the cohort is led by Halozyme Therapeutics Inc at 74/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
VIRP.PA Virbac SA 47 35 51 61 warn 18.3%
LLY Eli Lilly and Company 64 73 91 27 bull 8.8%
ORNAV.HE Orion Oyj A 62 81 83 32 ok 2.5%
ORNBV.HE Orion Oyj B 62 81 83 32 ok 2.4%
SAN.PA Sanofi SA 57 37 69 60 bear 17.1%
NVO Novo Nordisk A/S 55 26 86 74 bear 37.6%
GSK GlaxoSmithKline PLC ADR 52 28 79 57 info 21.9%
EL.PA EssilorLuxottica S. A. 44 9 45 58 bear 53.7%
ABVX.PA Abivax SA 37 12 53 55 warn 43.7%
HALO Halozyme Therapeutics Inc 74 94 94 48 ok 4.9%
DXCM DexCom Inc 66 85 80 35 bull 9.2%
ARGX.BR Argen-X 63 56 75 29 info 20.7%
ONC BeiGene, Ltd. 63 76 62 30 info 9%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-12

Quick answers

Who are Virbac SA's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Eli Lilly and Company (LLY), Orion Oyj A (ORNAV.HE), Orion Oyj B (ORNBV.HE), Sanofi SA (SAN.PA), Novo Nordisk A/S (NVO), GlaxoSmithKline PLC ADR (GSK), EssilorLuxottica S. A. (EL.PA), Abivax SA (ABVX.PA) and others.

How does VIRP.PA score against its peers?

Virbac SA's composite reads 47/100, ranking 11 of 13 in its cohort as of 2026-10-12; the cohort's highest composite is Halozyme Therapeutics Inc at 74/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.